Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.
about
Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overviewInflammation induced loss of skeletal muscleProinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection.Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.Influence of immune responses in gene/stem cell therapies for muscular dystrophies.Changes in circulating biomarkers of muscle atrophy, inflammation, and cartilage turnover in patients undergoing anterior cruciate ligament reconstruction and rehabilitation.Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membraneMacrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials.IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse.Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx miceAssociation of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor functionpSiM24 is a novel versatile gene expression vector for transient assays as well as stable expression of foreign genes in plants.SHP-1-dependent macrophage differentiation exacerbates virus-induced myositisPlatelet-rich plasma and skeletal muscle healing: a molecular analysis of the early phases of the regeneration process in an experimental animal model.Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophyIFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferationThe anti-inflammatory cytokine, interleukin-10, inhibits inflammatory mediators in human epithelial cells and mouse macrophages exposed to live and UV-inactivated Chlamydia trachomatis.Meeting Report: New Directions in the Biology and Disease of Skeletal Muscle 2014PEDF-derived peptide promotes skeletal muscle regeneration through its mitogenic effect on muscle progenitor cellsIncreases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide.The immune system in Duchenne muscular dystrophy: Friend or foe.IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration.Rotator cuff tear reduces muscle fiber specific force production and induces macrophage accumulation and autophagyThe PGC-1 coactivators promote an anti-inflammatory environment in skeletal muscle in vivo.Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia.Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage.Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization.Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy.Age-related loss of nitric oxide synthase in skeletal muscle causes reductions in calpain S-nitrosylation that increase myofibril degradation and sarcopenia.Tissue Tregs.Wasting mechanisms in muscular dystrophy.Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotypeMonocyte depletion increases local proliferation of macrophage subsets after skeletal muscle injuryKlotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy.Shared signaling systems in myeloid cell-mediated muscle regeneration.Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors.Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicineMacrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration.Mechanisms of muscle injury, repair, and regeneration.
P2860
Q26849430-411C60CB-2A25-471C-A67E-D03955B0FD3CQ28083759-02FD1BC0-3580-4850-99C0-A2C5ECD139DDQ30398612-BDC816CD-AD6A-48A0-8AAF-F6934E0E0D0CQ30841381-1D605B9B-57DF-4C9B-AAF6-D8D18271F7A8Q33736192-B8B47F3D-516E-41C5-A517-299ABCA9930EQ33862685-FF9F97EE-06CA-4646-86DC-DBC75C7C8356Q34049251-ABB1A005-5B6C-4EF0-9992-9BAA910DB691Q34240471-C1256E19-0958-43A3-A7FD-8B8D716CF0BCQ34310898-18209BB7-24EE-4FF1-990A-AF0266D78099Q34973330-57AC06CD-BFB3-4A96-9FFA-B218321BBC8AQ35016930-9320CCC8-E491-439A-8174-BDACD7108672Q35155971-5EC52917-A8F0-4E5F-8EF0-E0ADBFBA911FQ35181642-D8143171-B7EA-4C83-B880-078AA3227A29Q35183147-3382BA49-3DFB-4AE1-A140-BBF786E42550Q35211526-D07A9514-A05C-4E99-803F-DE3814D4339CQ35234073-04997BB6-2569-47D6-9E29-390D0A8EB616Q35523128-0BC2A4EA-447B-4A8D-8655-012530338E9FQ35864409-A056FCD9-DF9D-4B3B-9CE4-C89BC2F018CAQ35869849-2238CE51-9378-4ACB-A65B-A2D1571252B2Q35916727-F590FB1C-6908-4B48-89EA-EEFCE29AD43AQ35935193-049E2ABB-9BAD-4C51-86DF-77B4CF3C1EFFQ36105761-774E7605-90F4-45F5-BA13-B0415D0CAF33Q36252477-889B403B-8371-4B64-9DD8-F83D9F7B6883Q36253282-772EB928-DABF-41F0-AAF3-4A2022A71544Q36310526-05D89AA4-69D6-4353-9C6B-EF6BD04D3712Q36426745-C624B1A1-3CB5-4D22-80FC-8753965E47F2Q36593335-1E9B4A05-8094-4767-8CB8-B61D5F0A6149Q36756794-77AEDF39-4675-4FE7-BDD9-90798C060E4BQ36957496-C12552A5-898E-445D-B414-C05E9448030EQ37073715-D1DA8E57-8396-4EAE-AD88-DB47D276E51FQ37088061-FB25BD4F-81E6-4310-8807-F77B17480551Q37138490-BDF2F618-CE5F-4B3A-A2B4-93B102EABE6AQ37374329-3270A29D-22B2-409B-97B4-87777653B8D9Q37425909-107D737C-0EF6-4C42-8A7E-BDB6D3C3D02EQ37530224-12A80B43-194E-418C-84F6-498D02B04C1FQ37618669-F913C382-EAFE-43B2-9805-C28C366EF2B6Q37663675-627898AA-1D8B-4A3C-91EA-8D6FBC34C85DQ37990243-92B4A938-2A29-4518-96DF-40C43395044CQ38008341-999186C1-1DFD-4A85-BCDC-10AA2C731BFFQ38111732-DE5E3357-9F58-48FD-A8A3-484AC0BE0814
P2860
Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@ast
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@en
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@nl
type
label
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@ast
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@en
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@nl
prefLabel
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@ast
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@en
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@nl
P2093
P2860
P921
P356
P1476
Interleukin-10 reduces the pat ...... dulating macrophage phenotype.
@en
P2093
Brian Fedor
Chiara Rinaldi
James G Tidball
S Armando Villalta
P2860
P304
P356
10.1093/HMG/DDQ523
P577
2010-11-30T00:00:00Z